STAGE IA3 LUNG CANCER AJCC V8
Clinical trials for STAGE IA3 LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IA3 LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IA3 LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug shows promise in preventing lung cancer recurrence
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab could help prevent lung cancer from coming back in people with early-stage non-small cell lung cancer or high-risk lung nodules. Forty-five participants received the drug, and researchers tracked tumor response and su…
Matched conditions: STAGE IA3 LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Apr 29, 2026 02:37 UTC
-
Tiny heart monitor spies hidden damage during cancer radiation
Knowledge-focused CompletedThis study looked at how radiation treatment for lung or esophageal cancer affects the heart. 24 patients received a small implanted heart monitor to track changes that might otherwise go unnoticed. The goal was to find early signs of heart problems so they can be treated sooner …
Matched conditions: STAGE IA3 LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 29, 2026 02:38 UTC